Christine Sam is an Oncology physician affiliated with Moffitt Cancer Center. OpenAlex indexes 69 publications with 731 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
12902 Usf Magnolia Dr
Tampa, FL 336129416
Telephone
813-745-4673Provider last certified this registry record 26 Sept 2025.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Tempus AI, IncProgram year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20241 payment
- Dendreon Pharmaceuticals LLCProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
64.7%Aromatase Inhibitor44.2%Letrozole74%Anastrozole18%Exemestane8%Part D<11 patientsKinase inhibitor6.7%Ibrance53%Cabometyx28%Everolimus18%Part D<11 patients+ 4 more classes in this area
Nervous system
20.7%Phenothiazine6.8%Prochlorperazine Maleate100%Part D≥54 patientsOpioid Agonist4.9%Oxycodone Hcl52%Tramadol Hcl48%Part D≥16 patients+ 4 more classes in this area
Metabolism & gastrointestinal
9.3%Antidiarrheal3%Diphenoxylate-Atropine100%Part D≥16 patientsCorticosteroid2.8%Prednisone100%Part D≥14 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clinical Reasoning AI for Oncology Treatment Planning: A Multi-Specialty Case-Based Evaluation
arXiv (Cornell University)
2026 - A ten-year analysis of drug-facilitated crimes: Prevalence and characteristics at a tertiary hospital victim protection center
Forensic Science International
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Ignacio Wistuba, MD
Moffitt Cancer Center
Christine Chung, MD
Moffitt Cancer Center
Peter Forsyth, MD
Moffitt Cancer Center
Eric Haura, MD
Moffitt Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”